Association between Gut Microbiota and Digestive System Cancers: A Bidirectional Two-Sample Mendelian Randomization Study
Nutrients · 28.06.2023 · 15 (13) · 2937
DOI: 10.3390/nu15132937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 28.06.2023. Verfasst von Ning Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710049, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Digestive System Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The study was supported by grants from the National Key Technology R&D Program of China, the National Key Technology R&D Program of China.
Abstract (Originalsprache)
Accumulating evidence indicates that gut microbiota closely correlates with the tumorigenesis of digestive system cancers (DSCs). However, whether the causality between gut microbiota and DSCs exists is unknown. Genome-wide association study (GWAS) summary statistics for gut microbiota and DSCs and the bidirectional two-sample Mendelian randomization (MR) analysis were utilized to assess the causality between gut microbiota and DSCs. Sensitivity analyses were performed to evaluate the robustness of our results. We found that the genus Eggerthella (OR = 0.464, 95%CI: 0.27 to 0.796, p = 0.005) was negatively associated with the risk of gastric cancer. The genetically predicted genus Lachnospiraceae FCS020 group (OR = 0.607, 95%CI: 0.439 to 0.84, p = 0.003) correlated with a lower risk of colorectal cancer, and genus Turicibacter (OR = 0.271, 95%CI: 0.109 to 0.676, p = 0.005) was a protective factor for liver cancer. In the reverse MR, DSCs regulated the relative abundance of specific strains of gut microbiota. We comprehensively screened the association between gut microbiota and DSCs using a bidirectional two-sample MR analysis and identified the causality between several microbial taxa and DSCs. Our discoveries are beneficial for the development of novel microbial markers and microbiota-modifying therapeutics for DSC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710049, China.
- Bioinspired Engineering and Biomechanics Center (BEBC), Xi'an Jiaotong University, Xi'an 710049, China.
- National Clinical Research Center for Digestive Diseases, State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi'an 710032, China.
ORCID-Profile: Daiming Fan
Förderung
- The study was supported by grants from the National Key Technology R&D Program of China
- the National Key Technology R&D Program of China
Zitieren
APA
Xie, N., Wang, Z., Shu, Q., Liang, X., Wang, J., Wu, K., Nie, Y., Shi, Y., Fan, D., & Wu, J. (2023). Association between Gut Microbiota and Digestive System Cancers: A Bidirectional Two-Sample Mendelian Randomization Study. Nutrients, 15(13), 2937. https://doi.org/10.3390/nu15132937
Vancouver
Xie N, Wang Z, Shu Q, Liang X, Wang J, Wu K, et al. Association between Gut Microbiota and Digestive System Cancers: A Bidirectional Two-Sample Mendelian Randomization Study. Nutrients. 2023;15(13):2937. doi:10.3390/nu15132937
BibTeX
@article{Xie2023,
author = {Xie, Ning and Wang, Ziwei and Shu, Qiuai and Liang, Xiru and Wang, Jinhai and Wu, Kaichun and Nie, Yongzhan and Shi, Yongquan and Fan, Daiming and Wu, Jian},
title = {Association between Gut Microbiota and Digestive System Cancers: A Bidirectional Two-Sample Mendelian Randomization Study},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {13},
pages = {2937},
doi = {10.3390/nu15132937}
}
EUVIMED